Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07265323

Effect of Physiologic Insulin Administration on Insulin Sensitivity and Cognition

Effect of Physiologic Insulin Intervention on Insulin Sensitivity and Cognition

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
8 (estimated)
Sponsor
Pennington Biomedical Research Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to determine if a weekly delivery of insulin at short intervals lasting up to 2 hours can improve insulin sensitivity and cognition in adults with Alzheimer's Disease. It will also provide information about the safety and feasibility of this intervention. The main questions it aims to answer are: Does the intervention improve insulin sensitivity (how the body uses glucose)? Does the intervention improve cognition, measured by the Montreal Cognitive Assessment (MoCA) and the Revised Memory and Behavior Problems Checklist (RMBPC)? What changes occur in brain glucose uptake (FDG-PET)? Participants will: Receive the intervention once a week for 6 months, with each session lasting up to 2 hours Complete cognitive assessments. Adverse events will be assessed throughout the study.

Conditions

Interventions

TypeNameDescription
OTHERPhysiological Insulin InterventionInsulin infusion every five minutes over approximately two hours for six months. Initially infusion will be weekly and then frequency will reduce based on participants' response.

Timeline

Start date
2025-12-01
Primary completion
2027-05-01
Completion
2027-05-01
First posted
2025-12-04
Last updated
2025-12-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07265323. Inclusion in this directory is not an endorsement.